This Week in Science

A team of Harvard University researchers reports in Science on its examination of insertion mutations into the EGFR exon 20 in non–small cell lung cancer. These mutations, the team notes, are associated with reduced sensitivity to tyrosine kinase inhibitors like gefitinib, erlotinib, and afatinib, which they confirmed in an in vitro study.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

The Vulnerabilities

This Week in Cell

Be Gone

This Week in Nature

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.

In Science this week: the Human Silencing Hub protein complex, and more.